Here are this week’s most popular tweets from the @F1000 feed, as well as our 150,000th published recommendation celebrations and some other interesting picks from Twitter…
With 2014 upon us and the nominations now closed, it’s time to announce the F1000 Specialist of the Year 2013. After a tremendously eventful year for the F1000 Specialists program, and as we look forward to another equally eventful one, we’re pleased to highlight the achievements of four outstanding F1000 Specialists, one of which we…
We’ve hit a major milestone on F1000Prime – we’ve just published our 150,000th article recommendation! Submissions of article recommendations have risen each year since we launched F1000Prime in 2002: in 2013 we received a whopping 16,654 submissions. This has been possible because of continued growth in the numbers of Faculty Members who select articles –…
Just before we broke up for the holidays at the end of last year we were lucky enough to have editorial board member and F1000Research author Professor Ali Mobasheri visit us in our London office. During the visit (and after the obligatory tea and biscuits!) we managed to capture on camera a brief overview of…
A round up of the start of the year’s most popular tweets from @F1000, along with the other stories we spotted on Twitter…
This has been quite a year for us in F1000Prime. Our development team was kept very busy this year, helping us build and launch our new Journal Clubs feature, a new interactive and personalized homepage, and enabling us to ‘follow’ articles and Faculty Members, as well as nominate articles. We launched a new initiative –…
A round up of this week’s most popular tweets from @F1000, along with a few other stories we spotted on Twitter…
As we approach the end of the year, we reflect on the achievements of our F1000 Specialists and welcome nominations for the F1000 Specialist of the Year 2013. Having only launched in June this year, the programme has grown rapidly, now standing as a network of over 130 scientists and clinicians worldwide. Already Specialists have…
Here are this week’s most popular tweets from the @F1000 feed, as well as some other interesting picks from Twitter…
Clinical trials acronyms – like them or loathe them, more and more study groups are now shoehorning these in (I’m looking at you, ENTICES trial, which supposedly stands for ‘ENoxaparin and TIClopidine after Elective Stenting’). Some acronyms are more believable, like the BBC-ONE trial (‘British Bifurcation Coronary study: Old, New, and Evolving strategies’), and others…
